Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HYPERTENSION
Volume 28, Issue 1, Pages 15-21
Publisher
Oxford University Press (OUP)
Online
2014-05-20
DOI
10.1093/ajh/hpu086
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predominance of AT1 Blockade Over Mas–Mediated Angiotensin-(1–7) Mechanisms in the Regulation of Blood Pressure and Renin–Angiotensin System in mRen2.Lewis Rats
- (2013) Jasmina Varagic et al. AMERICAN JOURNAL OF HYPERTENSION
- Olmesartan is More Effective Than Other Angiotensin Receptor Antagonists in Reducing Proteinuria in Patients With Chronic Kidney Disease Other Than Diabetic Nephropathy
- (2013) Takashi Ono et al. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
- Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?
- (2013) J. Wysocki et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria
- (2012) Se Eun Park et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Possible Involvement of Angiotensin-Converting Enzyme 2 and Mas Activation in Inhibitory Effects of Angiotensin II Type 1 Receptor Blockade on Vascular Remodeling
- (2012) Masaru Iwai et al. HYPERTENSION
- Enhanced Angiotensin II-Induced Cardiac and Aortic Remodeling in ACE2 Knockout Mice
- (2012) Mahmoud S. Alghamri et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice
- (2012) Renisha Nadarajah et al. KIDNEY INTERNATIONAL
- Increased Urinary Angiotensin-Converting Enzyme 2 in Renal Transplant Patients with Diabetes
- (2012) Fengxia Xiao et al. PLoS One
- Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition
- (2011) Shinji Inaba et al. JOURNAL OF HYPERTENSION
- ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy
- (2011) Amrisha Verma et al. MOLECULAR THERAPY
- Urinary angiotensin-converting enzyme 2 in patients with CKD
- (2011) SONOO MIZUIRI et al. NEPHROLOGY
- Urocanic acid as an efficient hydroxyl radical scavenger: a quantum theoretical study
- (2010) Saumya Tiwari et al. JOURNAL OF MOLECULAR MODELING
- Review: Angiotensin II type 1 receptor blockers: class effects versus molecular effects
- (2010) Shin-ichiro Miura et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Revised Equations for Estimated GFR From Serum Creatinine in Japan
- (2009) Seiichi Matsuo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
- (2009) G. Y. Oudit et al. DIABETES
- Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2
- (2009) Jan Wysocki et al. HYPERTENSION
- Molecule-specific Effects of Angiotensin II-Receptor Blockers Independent of the Renin-Angiotensin System
- (2008) T. W. Kurtz et al. AMERICAN JOURNAL OF HYPERTENSION
- Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease
- (2008) Julie R Ingelfinger CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy
- (2008) G. Wang et al. DIABETOLOGIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started